Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification ofN-methylnicotinamide andN-methyl-4-pyridone-3-carboxamide by1H nuclear magnetic resonance and high performance liquid chromatography
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Biomarkers
- Vol. 8 (3-4) , 240-271
- https://doi.org/10.1080/1354750031000149124
Abstract
This study identified two potential novel biomarkers of peroxisome proliferation in the rat. Three peroxisome proliferator-activated receptor (PPAR) ligands, chosen for their high selectivity towards the PPARα, -δ and -γ subtypes, were given to rats twice daily for 7 days at doses known to cause a pharmacological effect or peroxisome proliferation. Fenofibrate was used as a positive control. Daily treatment with the PPARα and -δ agonists produced peroxisome proliferation and liver hypertrophy. 1H nuclear magnetic resonance spectroscopy and multivariate statistical data analysis of urinary spectra from animals given the PPARα and -δ agonists identified two new potential biomarkers of peroxisome proliferation - N-methylnicotinamide (NMN) and N-methyl-4-pyridone-3-carboxamide (4PY) - both endproducts of the tryptophan-nicotinamide adenine dinucleotide (NAD+) pathway. After 7 days, excretion of NMN and 4PY increased 24- and three-fold, respectively, following high doses of fenofibrate. The correlation between total NMN excretion over 7 days and the peroxisome count was r=0.87 (r2=0.76). Plasma NMN, measured using a sensitive high performance liquid chromatography method, was increased up to 61-fold after 7 days' treatment with high doses of fenofibrate. Hepatic gene expression of aminocarboxymuconate-semialdehyde decarboxylase (EC 4.1.1.45) was downregulated following treatment with the PPARα and -δ agonists. The decrease was up to 11-fold compared with controls in the groups treated with high doses of fenofibrate. This supports the link between increased NMN and 4PY excretion and regulation of the tryptophan-NAD+ pathway in the liver. In conclusion, NMN, and possibly other metabolites in the pathway, are potential non-invasive surrogate biomarkers of peroxisome proliferation in the rat.Keywords
This publication has 29 references indexed in Scilit:
- Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profilesJournal of Pharmaceutical and Biomedical Analysis, 2002
- Dietary Linoleic Acid Alters .ALPHA.-Amino-.BETA.-carboxymuconate-.EPSILON.-semialdehyde Decarboxylase (ACMSD), a Key Enzyme of Niacin Synthesis from Tryptophan, in the Process of Protein Expression in Rat Liver.Journal of Nutritional Science and Vitaminology, 1998
- Change of Tryptophan-Niacin Metabolism in D-GalactosamineInduced Liver Injury in Rat.Journal of Nutritional Science and Vitaminology, 1997
- Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte CulturesAnnals of the New York Academy of Sciences, 1996
- Suppression of Rat Hepatic α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Activity by Linoleic Acid in Relation to Its Induction by Glucocorticoids and Dietary ProteinBioscience, Biotechnology, and Biochemistry, 1994
- Hepatic peroxisome proliferation in rodents and its significance for humansFood and Chemical Toxicology, 1993
- Effects of Various Dietary Fatty Acids onα-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase Activity in Rat LiverBioscience, Biotechnology, and Biochemistry, 1992
- Light microscopic morphometric analysis of peroxisomes by automatic image analysis: advantages of immunostaining over the alkaline DAB method.Journal of Histochemistry & Cytochemistry, 1992
- New synthesis of the 4- and 6-pyridones of 1-methylnicotinamide and 1-methylnicotinic acid (trigonelline)Analytical Biochemistry, 1979
- A Multiple Comparison Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association, 1955